Compare IMVT & HR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMVT | HR |
|---|---|---|
| Founded | 2018 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 7.3B |
| IPO Year | 2019 | 2006 |
| Metric | IMVT | HR |
|---|---|---|
| Price | $33.39 | $18.08 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 8 |
| Target Price | ★ $33.00 | $19.29 |
| AVG Volume (30 Days) | 1.3M | ★ 3.3M |
| Earning Date | 05-28-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 5.20% |
| EPS Growth | N/A | ★ 60.77 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,180,546,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.14 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $15.81 | $16.31 |
| 52 Week High | $45.42 | $22.04 |
| Indicator | IMVT | HR |
|---|---|---|
| Relative Strength Index (RSI) | 25.45 | 30.28 |
| Support Level | $23.66 | $16.70 |
| Resistance Level | $36.29 | $18.74 |
| Average True Range (ATR) | 1.32 | 0.30 |
| MACD | -0.48 | -0.03 |
| Stochastic Oscillator | 9.75 | 25.72 |
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The Company operates in a single operating segment and has one reportable segment, which includes all activities related to the discovery, development and manufacturing of its product candidates.
Healthcare Realty Trust Inc is a healthcare facility real estate investment trust. The company focuses on owning, leasing, and managing outpatient facilities and other healthcare properties. The company works to invest in outpatient facilities that are integral to a hospital's operations. It generates all of its revenue in the United States.